Skip to main content

Find Clinical Trials

Home
Conditions
Immunogenicity

Clinical trial condition

Immunogenicity

Explore clinical trials studying Immunogenicity. Study availability and eligibility vary by location and protocol.

23 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Immunogenicity trial results

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

NCT04051268

Conditions: Immunogenicity, Safety Issues
Locations: Jatinegara Primary Health Care Jakarta, Jakart, Indonesia

View Trial Details

Completed

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

NCT04961385

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations: Thananda Trakarnvanich Bangkok, Thailand

View Trial Details

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

NCT03460405

Conditions: Immunogenicity, Safety Issues
Locations: Puskesmas Jatinegara Jakarta, Indonesia

Puskesmas Senen Jakarta, Indonesia

View Trial Details

Completed

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

NCT01369927

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +10 more
Locations: Schneider Children's Hospital Petah Tikva, Israel

View Trial Details

Completed

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

NCT04015232

Conditions: Healthy Volunteers, Immunogenicity
Locations: Lambda Therapeutic Research Ltd. Ahmedabad, Gota, India

View Trial Details

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

NCT03680417

Conditions: Immunogenicity, Safety Issues
Locations: Child Health Dept. Dr. Soetomo Hospital, School of Medicine Airlangga Univ. Surabaya, East Java, Indonesia

View Trial Details

Completed

Gardasil Vaccination in Post Stem Cell Transplant Patients

NCT01092195

Conditions: Gardasil Vaccine, Immunogenicity, Stem Cell Transplant
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique

NCT01697007

Conditions: HIV, Immunogenicity, Safety, +1 more
Locations: Instituto Nacional de Saude Maputo, Mozambique

Muhimbili University of Health and Allied Sciences Dar es Salaam, Tanzania

Mbeya Medical Research Programme Mbeya, Tanzania

View Trial Details

Completed

A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants

NCT01399853

Conditions: Immunogenicity, Safety
Locations: Jiangsu Provincial Center for Diseases Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Real-world Immunogenicity of Anti-IL5/5a Antibody

NCT07567690

Conditions: Asthma, Biologics, Bronchial Diseases, +8 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details